These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 7714799

  • 21. Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency.
    Cline EJ, Scheffel U, Boja JW, Carroll FI, Katz JL, Kuhar MJ.
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1174-9. PubMed ID: 1545384
    [Abstract] [Full Text] [Related]

  • 22. CoMFA study of novel phenyl ring-substituted 3alpha-(diphenylmethoxy)tropane analogues at the dopamine transporter.
    Newman AH, Izenwasser S, Robarge MJ, Kline RH.
    J Med Chem; 1999 Sep 09; 42(18):3502-9. PubMed ID: 10479283
    [Abstract] [Full Text] [Related]

  • 23. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
    Wang W, Sonders MS, Ukairo OT, Scott H, Kloetzel MK, Surratt CK.
    Mol Pharmacol; 2003 Aug 09; 64(2):430-9. PubMed ID: 12869648
    [Abstract] [Full Text] [Related]

  • 24. In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428.
    Scheffel U, Pögün S, Stathis M, Boja JW, Kuhar MJ.
    J Pharmacol Exp Ther; 1991 Jun 09; 257(3):954-8. PubMed ID: 2046028
    [Abstract] [Full Text] [Related]

  • 25. Is Na(+) required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?
    Li LB, Cui XN, Reith MA.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr 09; 365(4):303-11. PubMed ID: 11919655
    [Abstract] [Full Text] [Related]

  • 26. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
    Boja JW, Carroll FI, Vaughan RA, Kopajtic T, Kuhar MJ.
    Synapse; 1998 Sep 09; 30(1):9-17. PubMed ID: 9704876
    [Abstract] [Full Text] [Related]

  • 27. Severe depletion of cocaine recognition sites associated with the dopamine transporter in Parkinson's-diseased striatum.
    Kaufman MJ, Madras BK.
    Synapse; 1991 Sep 09; 9(1):43-9. PubMed ID: 1796351
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Isothiocyanate derivatives of 9-[3-(cis-3,5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole): irreversible ligands for the dopamine transporter.
    Husbands SM, Izenwasser S, Loeloff RJ, Katz JL, Bowen WD, Vilner BJ, Newman AH.
    J Med Chem; 1997 Dec 19; 40(26):4340-46. PubMed ID: 9435903
    [Abstract] [Full Text] [Related]

  • 30. Binding domains for blockers and substrates on the cloned human dopamine transporter studied by protection against N-ethylmaleimide-induced reduction of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)[3H]tropane ([3H]WIN 35,428) binding.
    Reith ME, Xu C, Coffey LL.
    Biochem Pharmacol; 1996 Nov 08; 52(9):1435-46. PubMed ID: 8937455
    [Abstract] [Full Text] [Related]

  • 31. Behavioral sensitization, behavioral tolerance, and increased [3H]WIN 35,428 binding in rabbit caudate nucleus after repeated injections of cocaine.
    Aloyo VJ, Pazdalski PS, Kirifides AL, Harvey JA.
    Pharmacol Biochem Behav; 1995 Oct 08; 52(2):335-40. PubMed ID: 8577799
    [Abstract] [Full Text] [Related]

  • 32. Differential relationships among dopamine transporter affinities and stimulant potencies of various uptake inhibitors.
    Izenwasser S, Terry P, Heller B, Witkin JM, Katz JL.
    Eur J Pharmacol; 1994 Oct 03; 263(3):277-83. PubMed ID: 7843265
    [Abstract] [Full Text] [Related]

  • 33. Drug interactions with the dopamine transporter in cryopreserved human caudate.
    Eshleman AJ, Wolfrum K, Mash DC, Christensen K, Janowsky A.
    J Pharmacol Exp Ther; 2001 Feb 03; 296(2):442-9. PubMed ID: 11160629
    [Abstract] [Full Text] [Related]

  • 34. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
    Xu C, Coffey LL, Reith ME.
    Biochem Pharmacol; 1995 Jan 31; 49(3):339-50. PubMed ID: 7857321
    [Abstract] [Full Text] [Related]

  • 35. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121.
    Staley JK, Boja JW, Carroll FI, Seltzman HH, Wyrick CD, Lewin AH, Abraham P, Mash DC.
    Synapse; 1995 Dec 31; 21(4):364-72. PubMed ID: 8869167
    [Abstract] [Full Text] [Related]

  • 36. O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
    Madras BK, Reith ME, Meltzer PC, Dutta AK.
    Eur J Pharmacol; 1994 Apr 15; 267(2):167-73. PubMed ID: 8050478
    [Abstract] [Full Text] [Related]

  • 37. Characterization of a recombinant human dopamine transporter in multiple cell lines.
    Eshleman AJ, Neve RL, Janowsky A, Neve KA.
    J Pharmacol Exp Ther; 1995 Jul 15; 274(1):276-83. PubMed ID: 7616409
    [Abstract] [Full Text] [Related]

  • 38. [125I]RTI-55 binding to cocaine-sensitive dopaminergic and serotonergic uptake sites in the human brain.
    Little KY, Kirkman JA, Carroll FI, Breese GR, Duncan GE.
    J Neurochem; 1993 Dec 15; 61(6):1996-2006. PubMed ID: 8245956
    [Abstract] [Full Text] [Related]

  • 39. Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects.
    Katz JL, Izenwasser S, Terry P.
    Psychopharmacology (Berl); 2000 Jan 15; 148(1):90-8. PubMed ID: 10663422
    [Abstract] [Full Text] [Related]

  • 40. Distribution of cocaine recognition sites in monkey brain: I. In vitro autoradiography with [3H]CFT.
    Kaufman MJ, Spealman RD, Madras BK.
    Synapse; 1991 Nov 15; 9(3):177-87. PubMed ID: 1776130
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.